(Q37768235)

22 August 2017

1 reference

title

Clinical use of biomarkers of survival in pulmonary fibrosis (English)

1 reference

22 August 2017

0 references

1 reference

1

Michiel Thomeer

1 reference

22 August 2017

Jan C Grutters

2

1 reference

22 August 2017

Wim A Wuyts

series ordinal

3

1 reference

22 August 2017

Stijn Willems

series ordinal

4

1 reference

22 August 2017

Maurits G Demedts

series ordinal

5

1 reference

22 August 2017

28 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

89

1 reference

Strategies for treating idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Challenges in pulmonary fibrosis: 8--The need for an international registry for idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Diagnosis of interstitial lung diseases.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Primer: establishing a clinical trial unit - regulations and infrastructure

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

High-dose acetylcysteine in idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Standardisation of spirometry

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

The clinical course of patients with idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

The epidemiology of interstitial lung disease and its association with lung cancer

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Proteomic strategies for biomarker identification: progress and challenges

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Determinants of survival in idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Determinants of progression in idiopathic pulmonary fibrosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Prognosis of cryptogenic fibrosing alveolitis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

High resolution computed tomography as a predictor of lung histology in systemic sclerosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Solute permeability of the alveolar capillary barrier

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Circulating KL-6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

CT evaluation of fibrosing alveolitis--applications and insights

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

The architecture of diagnostic research

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Comparison of spirometry performed on the same subjects by two teams using similar instruments: an investigation of variability in prevalence of impairment

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Pulmonary clearance of 99mTc-DTPA in the diagnosis and evolution of increased permeability pulmonary oedema

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

European reference equations for CO and NO lung transfer.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Pertechnegas lung clearance in different forms of interstitial lung disease.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Changes in Pulmonary Function Test Results After 1 Year of Therapy as Predictors of Survival in Patients With Idiopathic Pulmonary Fibrosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2907324

Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-11-89

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-11-89

The epidemiology of interstitial lung diseases

21 January 2018

1 reference

12 December 2020

Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis

1 reference

12 December 2020

Serum LDH: a marker of disease activity and its response to therapy in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Serum lactate dehydrogenase and its isoenzyme pattern in ex-coalminers

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

12 December 2020

CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis

1 reference

12 December 2020

Serum lactate dehydrogenase activity: indicator of the development of pneumonitis induced by amiodarone

1 reference

12 December 2020

Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis

1 reference

12 December 2020

Increased pertechnegas lung clearance in interstitial lung disease

1 reference

12 December 2020

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

12 December 2020

Analysis of KL-6 and SP-D as disease markers in bird fancier's lung

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis

1 reference

12 December 2020

Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent

1 reference

12 December 2020

The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction

1 reference

12 December 2020

KL-6 as a serum marker for amiodarone-induced pulmonary toxicity

1 reference

12 December 2020

The prognostic significance of functional tests in cryptogenic fibrosing alveolitis

1 reference

12 December 2020

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Small changes in six-minute walk distance are important in diffuse parenchymal lung disease

1 reference

12 December 2020

Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis

1 reference

12 December 2020

New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6

1 reference

12 December 2020

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

12 December 2020

Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT

1 reference

12 December 2020

Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation

1 reference

12 December 2020

Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-11-89

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference

22 August 2017

PubMed publication ID

20584284

1 reference